← brief for 2026-10-14 · Slowing decline

Gliflozin-Derived SGLT2 Inhibitors: Recent Advances and Future Perspectives in the Management of Type 2 Diabetes.

Article No results yet Peer reviewed

Key takeaways

This review covers a class of diabetes drugs called SGLT2 inhibitors. It looks at how they work and their effects on the heart and kidneys. It is a summary of past studies, not a new trial. It helps explain why these drugs are now widely used for kidney protection.

Who did this work

Prusty B · Rout SS · Saha A

Source

Article · PubMed, the drug frontier · 2026 Oct 13
https://pubmed.ncbi.nlm.nih.gov/42872647/